# TREATMENT ALLOCATION IN CLINICAL TRIALS/EFFICIENT

> **NIH NIH R01** · DANA-FARBER CANCER INST · 1988 · $97,157

## Abstract

We plan to continue our investigations regarding the efficiency of
designs for clinical trials and epidemiologic studies.  We shall
expand our survey of cancer clinical trials to examine the relation
of the design used to the quality of the study and the nature of
the results obtained.  We shall analyze a breast cancer case-
control study to explore the practical application of the
methodology we have developed for case-control studies with
prevalent cases.  We shall further explore this model to better
understand the limitations of its stationarity assumptions, and its
usefulness in analyzing matched data.

## Key facts

- **NIH application ID:** 3172872
- **Project number:** 5R01CA035291-06
- **Recipient organization:** DANA-FARBER CANCER INST
- **SAM.gov UEI:** DPMGH9MG1X67
- **Principal Investigator:** Colin B Begg
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 1988
- **Award amount:** $97,157
- **Award type:** 5
- **Project period:** 1983-06-01 → 1989-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/3172872

## Citation

> US National Institutes of Health, RePORTER application 3172872, TREATMENT ALLOCATION IN CLINICAL TRIALS/EFFICIENT (5R01CA035291-06). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/3172872. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*